About Semba Biosciences
Semba Biosciences is a company based in Madison (United States) founded in 2005 was acquired by Tosoh Bioscience in October 2021. Semba Biosciences has raised $5.85 million across 10 funding rounds from investors including Wisconsin Department of Commerce, Tosoh Bioscience and WEDC. Semba Biosciences operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and BIA Separations, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Semba Biosciences Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.85 M (USD)
in 10 rounds
-
Latest Funding Round
$3 M (USD), Series A
Nov 29, 2018
-
Investors
Wisconsin Department of Commerce
& 5 more
-
Employee Count
Not available
-
Acquired by
Tosoh Bioscience
(Oct 04, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Semba Biosciences
Semba Biosciences has successfully raised a total of $5.85M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Semba Biosciences
Semba Biosciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Wisconsin Department of Commerce, Tosoh Bioscience and WEDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed venture capital funding is provided by Kegonsa Seed Fund.
|
Locked | Locked | Locked | |
|
Offers biomolecular separation instruments and clinical analyzers for healthcare applications.
|
Locked | Locked | Locked | |
|
Economic development support is provided for businesses and communities in Wisconsin.
|
Locked | Locked | Locked |
Investor details for Semba Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Semba Biosciences
Investment portfolio details for Semba Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Semba Biosciences
Detailed financials for Semba Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Semba Biosciences Comparisons
Peer comparison for Semba Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Semba Biosciences
Semba Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and BIA Separations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provides liquid chromatography solutions
|
|
| Locked | Locked | Locked |
Monolithic chromatographic columns are developed using Convective Interaction Media technology.
|
|
| Locked | Locked | Locked |
Biomolecular separation technologies are enabled for bioprocessing applications.
|
Detailed competitors of Semba Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Semba Biosciences
Complete news archive for Semba Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Semba Biosciences
Semba Biosciences was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Semba Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Semba Biosciences is a funded company, having raised a total of $5.85M across 10 funding rounds to date.
Semba Biosciences was founded in 2005 in Madison, United States, and operates in the biotechnology sector. Continuous chromatography platforms for process development and single-use manufacturing are offered, along with columns for small molecule and biomolecular separation, and related reagents. These products are applied in the separation of monoclonal antibodies, recombinant proteins, natural products such as nutraceuticals and food ingredients, sugars, amino acids, organic acids, fatty acids, and enantiomers.
Semba Biosciences's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Semba Biosciences has 6 investors. Key investors include Wisconsin Department of Commerce, Tosoh Bioscience, WEDC, Wisconsin SBIR, and Madison Development.